Clinical Trial Update: A Study of Dulanermin Administered in Combination With Camptosar®/Erbitux® Chemotherapy or FOLFIRI (With or Without Bevacizumab) in Subjects With Previously Treated Metastatic Colorectal Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating dulanermin in combination with irinotecan-based chemotherapy (Camptosar/Erbitux) or FOLFIRI (with or without bevacizumab) for previousl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Camptosar (irinotecan)
• Dulanermin (dulanermin)
• ERBITUX (cetuximab)

Snippet

Sponsor: Genentech, Inc. | Conditions: Colorectal Cancer | Phase 1 | Status: COMPLETED